PROGRESS IN LIPID RESEARCH

metrics 2024

Connecting Research and Health Through Lipids

Introduction

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.

Metrics 2024

SCIMAGO Journal Rank3.64
Journal Impact Factor14.00
Journal Impact Factor (5 years)15.70
H-Index168
Journal IF Without Self14.00
Eigen Factor0.00
Normal Eigen Factor0.92
Influence3.55
Immediacy Index2.00
Cited Half Life10.10
Citing Half Life9.80
JCI1.66
Total Documents618
WOS Total Citations7497
SCIMAGO Total Citations22112
SCIMAGO SELF Citations290
Scopus Journal Rank3.64
Cites / Document (2 Years)14.82
Cites / Document (3 Years)15.35
Cites / Document (4 Years)16.48

Metrics History

Rank 2024

Scopus

Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #7/438
Percentile 98.40
Quartile Q1
Cell Biology in Biochemistry, Genetics and Molecular Biology
Rank #14/285
Percentile 95.09
Quartile Q1

IF (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 8/313
Percentile 97.60
Quartile Q1
NUTRITION & DIETETICS
Rank 1/114
Percentile 99.60
Quartile Q1

JCI (Web Of Science)

BIOCHEMISTRY & MOLECULAR BIOLOGY
Rank 23/313
Percentile 92.65
Quartile Q1
NUTRITION & DIETETICS
Rank 4/114
Percentile 96.49
Quartile Q1

Quartile History

Similar Journals

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Advancing insights into endocrinology and metabolism.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1849Frequency: 12 issues/year

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Advancing the Frontiers of Lipid Biology
Publisher: ELSEVIERISSN: 1388-1981Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, published by Elsevier, is a leading academic journal that focuses on advancing the field of lipid biology. With an ISSN of 1388-1981 and an E-ISSN of 1879-2618, this journal has established itself as an essential resource for researchers, professionals, and students interested in cell and molecular biology, particularly regarding lipid interactions and functions. The journal boasts an impressive impact factor, standing in the top quartiles of its categories—Q1 in Molecular Biology and Q2 in Cell Biology. As part of the vibrant academic landscape of the Netherlands, it supports both traditional and open access publication models, ensuring that vital research is accessible to a global audience. The converged years from 1998 to 2025 mark its sustained commitment to quality and relevance in the fast-evolving field of lipid research. With a strong ranking in Scopus and a percentile in the 80th range in both Molecular Biology and Cell Biology, this journal continues to be a pivotal platform for scholarly communication and innovation in lipid-related research.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Transforming cardiovascular health through impactful discoveries.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Pioneering Discoveries in Essential Fatty Acid Science
Publisher: ELSEVIER SCI LTDISSN: 0952-3278Frequency: 12 issues/year

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS is a distinguished peer-reviewed journal dedicated to advancing the understanding of the biological roles of prostaglandins, leukotrienes, and essential fatty acids in human health and disease. Published by Elsevier Science Ltd, this journal has been at the forefront of research since its inception in 1988 and continues to serve as a vital resource for researchers, clinicians, and students involved in the fields of biochemistry and cell biology. With its impact factor reflecting a solid academic presence—ranking Q3 in Cell Biology and Q2 in Clinical Biochemistry in 2023—this journal is recognized for its quality contributions, particularly in uncovering the biochemical pathways and clinical implications of these lipid mediators. Though not an open-access journal, it provides various access options to ensure the dissemination of critical findings. As the field evolves, PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS remains a pivotal platform for the exploration and discussion of new methodologies, therapeutic avenues, and biological discoveries that impact patient care and the foundational sciences.

Journal of Atherosclerosis and Thrombosis

Elevating the standards of cardiovascular research and discovery.
Publisher: JAPAN ATHEROSCLEROSIS SOCISSN: 1340-3478Frequency: 12 issues/year

Journal of Atherosclerosis and Thrombosis is a leading academic publication dedicated to advancing research in the fields of cardiovascular medicine, biochemistry, and internal medicine. Published by the Japan Atherosclerosis Society, this esteemed journal operates from its headquarters in Tokyo, Japan, and has been a vital resource in its area since its inception in 1994. With its robust impact in Cardiology and Cardiovascular Medicine, ranking in the top quartile (Q1) as of 2023, and a commendable standing in Internal Medicine and Biochemistry, the journal fosters an environment of innovation and discovery, showcasing significant studies and advancements that shape clinical practices and therapeutic approaches. Though not an open-access publication, it offers a wealth of insights to researchers, professionals, and students seeking to deepen their understanding of atherosclerosis and thrombosis. By continually featuring high-quality articles, the Journal of Atherosclerosis and Thrombosis plays an essential role in bridging the gap between research and practice, facilitating critical conversations that influence the future of cardiovascular health.

JOURNAL OF MEMBRANE BIOLOGY

Decoding Membrane Mechanisms for Tomorrow's Science
Publisher: SPRINGERISSN: 0022-2631Frequency: 6 issues/year

Welcome to the Journal of Membrane Biology, a premier publication dedicated to advancing our understanding of the complex roles membranes play in biological systems. Published by Springer, this journal features research articles, reviews, and communications on a broad range of topics related to membrane biology, including biomolecular interactions, transport mechanisms, and physiological responses. With an ISSN of 0022-2631 and E-ISSN 1432-1424, the journal has been a cornerstone in the field since its inception in 1969 and continues to thrive as it looks towards 2024. Ranked in the second quartile (Q2) for Biophysics and Physiology, and third quartile (Q3) in Cell Biology, it showcases impactful research that embodies the spirit of scientific inquiry and innovation. Although currently not an Open Access journal, it remains easily accessible to researchers, professionals, and students eager to delve into the dynamic world of membrane studies. As the understanding of membrane dynamics expands, so does its relevance in areas such as drug development and cellular engineering, making the Journal of Membrane Biology an essential resource for those at the forefront of these critical scientific advancements.

Nature Metabolism

Pioneering research at the forefront of metabolic science.
Publisher: NATURE PORTFOLIOISSN: Frequency: 12 issues/year

Nature Metabolism, published by NATURE PORTFOLIO, is a leading journal dedicated to advancing the field of metabolic research and its implications across various biological systems. Since its inception in 2019, this esteemed journal has rapidly established itself as a vital resource for researchers, professionals, and students alike, reflecting its prominence through a prestigious Q1 ranking in several key categories including Cell Biology, Endocrinology, Diabetes and Metabolism, Internal Medicine, and Physiology. With an impressive Scopus ranking, underscoring its impact in Medicine and Biochemistry disciplines, Nature Metabolism offers an exceptional platform for disseminating high-quality research that explores the intricate mechanisms of metabolism and its association with health and disease. Although currently not open access, it continues to gain visibility and appreciation within the scientific community, ensuring that groundbreaking findings reach interested audiences globally from its hub in Berlin, Germany. Whether you are an experienced researcher or an aspiring student, Nature Metabolism serves as an invaluable asset in navigating the complexities of metabolic science.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Illuminating the Pathways of Cellular Energy
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0145-479XFrequency: 6 issues/year

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Pioneering Research in Biochemistry and Biophysics
Publisher: ELSEVIERISSN: 0005-2736Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES is a prestigious journal dedicated to advancing the field of biomembrane research, published by Elsevier. With a notable track record since its inception in 1967, this journal operates under the dual ISSN 0005-2736 and E-ISSN 1879-2642, and has firmly established itself within the scientific community by ranking in the top tiers of various disciplines, including Q2 in Biochemistry and Cell Biology, and Q1 in Biophysics as of 2023. Its impressive Scopus rankings further underscore its importance, with a rank of 24 in Biophysics reflecting its strong impact on ongoing research. Although it does not offer open access, the journal provides comprehensive insights and breakthroughs essential for scientists, researchers, and advanced students focused on biophysical and biochemical aspects of membranes. By disseminating pivotal findings, BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES contributes significantly to understanding cellular mechanisms, thereby serving as a vital resource for professionals aiming to explore the complexities of biological membranes.

LIPIDS

Bridging disciplines through lipid exploration.
Publisher: WILEYISSN: 0024-4201Frequency: 6 issues/year

LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.